معرفی
Professor Karl Hawkins is a faculty member at Swansea University's Faculty of Medicine, Health and Life Science, working within the Biomedical Sciences department. He serves as Director of the Centre for NanoHealth at the Swansea University Medical School. His research focuses on developing novel biomarkers of blood coagulation using advanced rheological techniques. With over 70 peer-reviewed publications, his work spans fluid mechanics, medical devices, and hematology. Hawkins has secured significant funding (exceeding £6M) from EPSRC, MRC, and industry partners, leading projects like the Engineering Blood Diagnostics Platform Grant. He is an active member of rheology communities, including roles as Secretary of the British Society of Rheology and Director of the Institute of Non-Newtonian Fluid Mechanics.
Research Interests: Professor Hawkins specializes in bio-rheology, biopolymer gels, and hemocompatibility of medical devices. His work bridges fundamental rheology with clinical applications, aiming to improve diagnostic tools and therapies for thrombotic disorders. Recent studies explore clot microstructure in conditions like ST-elevation myocardial infarction and severe COVID-19, emphasizing biomarker development for therapeutic efficacy assessment.
Publications Highlight: His recent work examines clot microstructure alterations in diseases such as myocardial infarction and COPD exacerbations, with studies on fibrinolysis impairment in severe COVID-19 and the efficacy of anticoagulants like rivaroxaban. He also contributes to 3D bioprinting innovations using nanocellulose-based bioinks for tissue engineering.
Grants & Leadership: As Co-Investigator on EPSRC grants and Principal Investigator of an EPSRC first grant, Hawkins advances haemorheological techniques for blood coagulation analysis. His leadership in collaborative networks like the Institute of Non-Newtonian Fluid Mechanics underscores his role in advancing interdisciplinary research.
Labs & Teams: Directs the Centre for NanoHealth, focusing on nanotechnology-driven health innovations. Collaborates with interdisciplinary teams on projects integrating rheology, biomaterials, and clinical diagnostics.
